BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33775714)

  • 21. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
    Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
    Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB‑EGF.
    Fu E; Liu T; Yu S; Chen X; Song L; Lou H; Ma F; Zhang S; Hussain S; Guo J; Sun J; Yu P; Mao X; Wei L
    Oncol Rep; 2020 Aug; 44(2):698-710. PubMed ID: 32627036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer.
    Ricco N; Flor A; Wolfgeher D; Efimova EV; Ramamurthy A; Appelbe OK; Brinkman J; Truman AW; Spiotto MT; Kron SJ
    Mol Oncol; 2019 Sep; 13(9):1927-1943. PubMed ID: 31225926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells
    Park JJ; Hah YS; Ryu S; Cheon SY; Cho HY; Kim JP; Won SJ; Lee JS; Hwa JS; Seo JH; Chang HW; Kim SY
    Anticancer Res; 2020 May; 40(5):2627-2635. PubMed ID: 32366407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cGAS Regulates the Radioresistance of Human Head and Neck Squamous Cell Carcinoma Cells.
    Nyui T; Yoshino H; Nunota T; Sato Y; Tsuruga E
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of lncRNA LINC00473 promotes radioresistance of HNSCC cells through activating Wnt/β-catenin signaling pathway.
    Han PB; Ji XJ; Zhang M; Gao LY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7305-7313. PubMed ID: 30468475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
    de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
    Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
    Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
    Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Four-Gene Signature Associated with Radioresistance in Head and Neck Squamous Cell Carcinoma Identified by Text Mining and Data Analysis.
    Zhang Y; Wang H; Wang F; Ma W; Li N; Bo C; Zhao Y; He L; Liu M
    Comput Math Methods Med; 2022; 2022():5693806. PubMed ID: 36203528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FN1 promotes prognosis and radioresistance in head and neck squamous cell carcinoma: From radioresistant HNSCC cell line to integrated bioinformatics methods.
    Tang X; Tang Q; Yang X; Xiao ZA; Zhu G; Yang T; Yang Q; Zhang Y; Li S
    Front Genet; 2022; 13():1017762. PubMed ID: 36212151
    [No Abstract]   [Full Text] [Related]  

  • 32. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
    Digomann D; Linge A; Dubrovska A
    Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
    Liu N; Boohaker RJ; Jiang C; Boohaker JR; Xu B
    Oncotarget; 2015 Oct; 6(33):34649-57. PubMed ID: 26452218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells.
    Jing Z; Guo S; Li Y; Liang Z
    Head Neck; 2022 Jan; 44(1):212-225. PubMed ID: 34731528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts.
    Linge A; Patil S; Grosser M; Lohaus F; Gurtner K; Kemper M; Gudziol V; Haim D; Nowak A; Tinhofer I; Zips D; Guberina M; Stuschke M; Balermpas P; Rödel C; Schäfer H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Boeke S; Gani C; Jöhrens K; Baretton GB; Löck S; Baumann M; Krause M;
    Radiother Oncol; 2024 Feb; 191():110055. PubMed ID: 38109944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
    Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
    J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC.
    Geyer F; Geyer M; Reuning U; Klapproth S; Wolff KD; Nieberler M
    Sci Rep; 2024 Apr; 14(1):8286. PubMed ID: 38594331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
    Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
    Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.